REGENXBIO Inc. | Key People and Executives
Donald J. Hayden
Chairman
Kenneth T. Mills
President, Chief Executive Officer & Director
Alexandra Glucksmann
Independent Director
Daniel Tassé
Independent Non-Executive Director
Daniel J. Abdun-Nabi
Independent Director
David C. Stump
Independent Director
Argeris N. Karabelas
Independent Director
Luke M. Beshar
Independent Director
Donald J. Hayden
Chairman
Kenneth T. Mills
President, Chief Executive Officer & Director
Vit Vasista
Chief Financial Officer
Stephen Yoo
Chief Medical Officer & Senior Vice President
Jerome W. Jackson
Vice President-Information Technology
Rickey Reinhardt
Vice President-Clinical Research & Development
Curran M. Simpson
Senior Vice President-Technical Operations
Laura A. Coruzzi
Senior Vice President-Intellectual Property
Shiva G. Fritsch
Senior Vice President-Human Resources
Sara Garon Berl
Secretary, Vice President-Law & Policy
Patrick J. Christmas
Senior Vice President & General Counsel
Lynne Fahey McGrath
Vice President-Regulatory Affairs
Alexandra Glucksmann
Independent Director
Daniel Tassé
Independent Non-Executive Director
Daniel J. Abdun-Nabi
Independent Director
David C. Stump
Independent Director
Argeris N. Karabelas
Independent Director
Luke M. Beshar
Independent Director
| Address |
9600 Blackwell Road
Rockville Maryland 20850
United States
|
|
Employees
|
- |
| Website |
http://www.regenxbio.com |
| Updated |
07/08/2019 |
| REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. |
